CXCL13 antibody for the treatment of autoimmune disorders.
about
Translational utility of experimental autoimmune encephalomyelitis: recent developmentsPotential of Cells and Cytokines/Chemokines to Regulate Tertiary Lymphoid Structures in Human DiseasesDevelopment and Function of Secondary and Tertiary Lymphoid Organs in the Small Intestine and the ColonThe Immunogenetics of Autoimmune CholestasisElevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remissionRegulated Production of CXCL13 within the Central Nervous System.The curious origins of angioimmunoblastic T-cell lymphomaUtility of CSF Cytokine/Chemokines as Markers of Active Intrathecal Inflammation: Comparison of Demyelinating, Anti-NMDAR and Enteroviral EncephalitisTargeting CXCL13 During NeuroinflammationCXCL13 is a plasma biomarker of germinal center activity.Circulating T follicular helper cells with increased function during chronic graft-versus-host diseaseNovel CXCL13 transgenic mouse: inflammation drives pathogenic effect of CXCL13 in experimental myasthenia gravis.Association of Serum CXCL13 with Intrarenal Ectopic Lymphoid Tissue Formation in Lupus Nephritis.Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.T cell specific Cxcr5 deficiency prevents rheumatoid arthritis.B Lymphocyte Chemoattractant (CXCL13) Is an Indicator of Acute Gastrointestinal GVHD in Murine Model.The role of Bruton's tyrosine kinase in autoimmunity and implications for therapy.Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers.Further understanding of the immunopathology of multiple sclerosis: impact on future treatments.Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem.Cerebrospinal fluid cyto-/chemokine profile during acute herpes simplex virus induced anti-N-methyl-d-aspartate receptor encephalitis and in chronic neurological sequelae.CXCL13 as a diagnostic marker of neuroborreliosis and other neuroinflammatory disorders in an unselected group of patients.Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosisNew Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis
P2860
Q26775820-A8B69D12-E7B5-4E19-AE31-C01A27481C40Q28071670-F1C7A481-4971-4383-835D-0E55EAF276D1Q28071695-180637CD-FD08-4789-8D71-AB8DF465D340Q28085346-1B71B430-D2C2-4FFA-AB77-2DD5D26DD682Q33562130-03B314CC-A52F-4141-AC55-670FBF6EDCC0Q33772300-95A16FB1-5EFB-4C56-B652-C4E9C8393CE7Q33877993-46BA9046-65BC-490C-968D-DA50C0AD22E0Q36117017-AF90C6FF-E7CE-4862-9045-19A5F8B5B3A6Q36551188-E5BBCFD8-149C-4C93-AB56-B4F11ECFA041Q36684710-F7811B8C-968E-484D-A2F7-50B3B55834BAQ36920466-479DA927-6C78-40EF-A10F-F209FB6E7E0BQ36946564-726E949F-21FD-4592-B19F-D14793198A59Q37470883-3977E2AB-0DFA-480A-8519-242E0C19CE7BQ37501812-9A24E5B9-FB67-4EA9-82AF-2B68CF7FC59AQ38615369-51C91ACC-B69D-47EC-885C-451CD30314A3Q38688669-E7160AC3-D081-43E5-8404-6D6EBB915646Q38728631-CCCBF773-0973-4644-9A91-7916F4A24201Q38810926-EC1253E9-033A-4769-95B8-875C379FB4B1Q38837294-59505995-06F8-4CE6-BFE1-4CF8D19139CEQ39108730-22F48740-668C-4820-BFE7-F5DC3BEE91D5Q40229229-65CBFB26-2B5E-43D0-8F7B-9444BBF75CF2Q47581475-81E13CBF-BBD4-4A9D-9259-C9A702F9A438Q55052878-E4045E35-AAB4-4758-9113-2DDDDC02B03EQ57825780-DD99E868-4533-44BE-9AB5-4FD1634F8AD1Q58803309-10A6AAEE-D2B2-4BF6-B564-A55506A45912
P2860
CXCL13 antibody for the treatment of autoimmune disorders.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
CXCL13 antibody for the treatment of autoimmune disorders.
@ast
CXCL13 antibody for the treatment of autoimmune disorders.
@en
type
label
CXCL13 antibody for the treatment of autoimmune disorders.
@ast
CXCL13 antibody for the treatment of autoimmune disorders.
@en
prefLabel
CXCL13 antibody for the treatment of autoimmune disorders.
@ast
CXCL13 antibody for the treatment of autoimmune disorders.
@en
P2093
P2860
P1433
P1476
CXCL13 antibody for the treatment of autoimmune disorders.
@en
P2093
Alan Jonason
Christine Reilly
Crystal Mallow
Ekaterina Klimatcheva
Ernest S Smith
Holm Bussler
Maria Scrivens
Mark Paris
Maurice Zauderer
Michael Doherty
P2860
P2888
P356
10.1186/S12865-015-0068-1
P577
2015-02-12T00:00:00Z
P5875
P6179
1018978976